GENE ONLINE|News &
Opinion
Blog

Richard Chau

WRITTEN BY Richard Chau

HanchorBio Showcases FBDB™ Platform and Global Strategy at BIO Asia-Taiwan 2026
2026-07-17
Global and Local Strategies Intersect at BIO Asia-Taiwan 2026 Plenary on Medicine Resilience
2026-07-15
HanchorBio and InxMed Explore “Barrier Disruption + Myeloid Activation” Strategy for Difficult-to-Treat Solid Tumors
2026-07-08
Biopharma Leaders Confront Operational Realities and Data Hurdles at BIO 2026 AI Summit
2026-07-02
Arizona and Taiwan Sign MOU to Foster Bilateral Biotech Exchange and Collaboration
2026-06-26
AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology and Respiratory Pipeline
2026-06-23
New Epigenetic Approach Revives Exhausted Immune Cells to Enhance Cancer Immunotherapy Outcomes
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
A Domino Effect in Motor Neurons Unveils the Long-Standing Mystery of ALS Progression and Survival
2026-06-15
GSK Bolsters Oncology Portfolio With $10.6 Billion Nuvalent Acquisition in its Third Major Deal in 2026
2026-06-09
Uncovering How Cellular Waste Buildup in the Brain Drives Aging and Neurodegenerative Diseases
2026-06-08
AI-Powered Blood Test Accurately Classifies Multiple Neurodegenerative Diseases And Detects Co-Existing Conditions
2026-06-06
Breakthrough RNA Segment Editing Technology Offers New Hope for Treating Neurodegenerative Diseases
2026-06-05
Navigating the Translational Future of Cancer Care with ASCO 2026 Late-Breaking Abstracts
2026-06-02
Precision Combinations and Novel Modalities Redefine Head and Neck Cancer Care at ASCO 2026
2026-05-29
1 2 3 14
Scroll to Top